Content about Merck

August 1, 2010
Merck discloses Q2 earnings

Merck had global sales of $11.3 billion and profits of $752 million during second quarter...

July 18, 2010
Kaletra-Isentress therapy for HIV patients as effective as standard treatments, drug makers say

A combination therapy comprising of drugs made by Abbott and Merck is as effective as...

July 7, 2010
Merck announces global consolidation plan

Merck will close down eight of its research and development sites and eight of its...

June 23, 2010
Merck gets nod from FDA for Dulera

The Food and Drug Administration has approved a new drug by Merck for treating asthma...

June 16, 2010
Mid-stage trial results positive for Merck's insomnia drug

An investigational treatment made by Merck for insomnia was more effective than placebo in improving...

June 6, 2010
Specialty Rx offers pharma a patent cliff parachute

While Big Pharma hurdles toward the edge of the patent cliff, some of the latest...

May 10, 2010
Glenmark, Par settle Zetia patent suit with Merck

Glenmark Generics has reached a settlement with Merck over a cholesterol drug, Glenmark partner Par...

April 20, 2010
MassBiologics grants licensing agreement to Merck for tetanus-diphtheria vaccine

A biotech developer owned by the University of Massachusetts Medical School has granted drug maker...

BOSTON A biotech developer owned by the University of Massachusetts Medical School has granted drug maker Merck exclusive U.S. rights to its tetanus and diphtheria vaccine, Merck announced Wednesday.

 

March 21, 2010
Merck responds to FDA warning of simvastatin use

Merck & Co. has responded to a warning by the Food and Drug Administration about...

February 28, 2010
AstraZeneca to buy drugs it developed with Merck

AstraZeneca plans to buy Merck & Co.’s interest in several drug products that the two...

February 28, 2010
Merck buys Millipore

Merck KGaA plans to buy a Massachusetts life sciences company for $7.2 billion, the German...

February 28, 2010
Merck's R&D pipeline gets a boost

Merck & Co.’s acquisition of Schering-Plough has delivered a big boost to the drug maker’s...

February 17, 2010
Merck accepting orders for seasonal flu vaccine from healthcare providers

Merck is allowing healthcare providers to pre-order the flu vaccine Afluria (influenza virus vaccine) for...

January 25, 2010
Teva wins patent battle over Merck's Temodar

Teva Pharmaceutical Industries may soon get the green light to market a generic drug for...

January 10, 2010
New P&G initiative may create clash of the OTC titans

This is shaping up to be a Fight Night dream card, with the battle arena...

WHAT IT MEANS AND WHY IT'S IMPORTANT This is shaping up to be a Fight Night dream card, with the battle arena located in the digestives aisle of a pharmacy near you. Are you ready to rumble?

(THE NEWS: P&G develops new program in line with Prilosec OTC. For the full story, click here)

December 3, 2009
Zegerid OTC approved as heartburn remedy

The digestives aisle will be altogether crowded come early 2010, especially with two new proton-pump...

NEW YORK The digestives aisle will be altogether crowded come early 2010, especially with two new proton-pump inhibitors on the shelf. And while there may be some question as to just how large sales of antacids can get, one thing is for sure: There will be a slew of advertisers vying for their own increased share of stomach.